Paramount Skydance Corp 8-K

What Happened

• Paramount Skydance Corp (PSKY) filed an 8-K (Regulation FD disclosure) reporting progress on its previously announced Agreement and Plan of Merger (dated Feb 27, 2026) to acquire Warner Bros. Discovery (WBD). Under the deal, Merger Sub will merge into WBD and WBD will survive as a wholly owned subsidiary of PSKY at the merger’s effective time.
• PSKY reported three recent regulatory developments: (1) the U.S. Department of Justice (DOJ) closed its investigation and on June 12, 2026 issued a statement saying the transaction is “not likely to result in harm to competition or American consumers” (including SVOD, linear TV, and studio film development/production); (2) China’s antitrust authority (Anti‑Monopoly Enforcement Department II of SAMR) granted unconditional clearance on June 17, 2026; and (3) Spain’s foreign direct investment authority provided a no‑jurisdiction confirmation on June 11, 2026.

Key Details

• Merger agreement date: February 27, 2026.
• DOJ statement closing investigation: June 12, 2026; cited no likely harm to competition (SVOD, linear TV, theatrical film).
• China clearance: Anti‑Monopoly Enforcement Department II of SAMR — unconditional clearance received June 17, 2026.
• Spain approval: General Directorate on Commercial Policy and Economic Security — no‑jurisdiction confirmation received June 11, 2026.

Why It Matters

• These regulatory clearances (U.S. DOJ closing its probe plus approvals/confirmations from China and Spain) reduce major antitrust uncertainty for the merger, making closing more likely if other conditions are met. For investors, that could affect timing and expected integration of WBD into PSKY, potential synergies, and PSKY’s future financial profile.
• The filing also includes a standard cautionary note on forward‑looking statements and lists numerous risks (e.g., remaining closing conditions, integration challenges, indebtedness, litigation, and market risks). Investors should review PSKY’s and WBD’s recent SEC filings (Form 10‑K and Form 10‑Q) for full risk details.